from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1211/-

LFCtreatmentdescriptionclass of inhibitor

1.463

Amikacinug/mL Amikacintranslation

0.969

Cap5-10ug/mL Capreomycintranslation

1.351

Rox10-50 ug/mL Roxithromycintranslation

0.266

SM2-5 ug/mL Streptomycintranslation

1.222

Tet5-10 ug/mL Tetracyclinetranslation

0.016

Rif0.2-5ug/mL Rifampicintranscription

0.457

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.084

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.785

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.008

CPZ10-50 ug/mL Chlorpromazinerespiration

0.096

Clofazimine10-13 ug/mL Clofaziminerespiration

0.722

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.074

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.486

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.601

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.825

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.529

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.086

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.401

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.090

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.060

KCN5-20 ug/mL Potassium cyaniderespiration

0.801

NaN30.2-2 mM Sodium aziderespiration

0.205

Nigericin50 uM Nigericinrespiration

-0.077

TRC10-150 ug/mL Triclosanrespiration

0.349

TRZ10-25 ug/mL Thioridazinerespiration

-1.346

Valinomycin0.5-10 uM Valinomycinrespiration

0.049

ZnSO42 mM ZnSO4respiration

-0.185

menadione6-10 ug/mL Menadionerespiration

-0.859

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-1.281

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-1.165

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.098

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.355

NRP_1Non-replicating persistence stage 1dosRassociated

-0.547

Amp0.2mg/mL AmpicillincellWall

0.224

Cephalexin20-100 ug/mL CephalexincellWall

-0.060

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.315

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.140

EMB10-20 ug/mL EthambutolcellWall

0.826

Eta12-40 ug/mL EthionamidecellWall

0.997

INH0.2-0.4 ug/mL IsoniazidcellWall

0.399

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.547

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.068

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.222

BZA0.12 mg/mL BenzamidearomaticAmides

-0.215

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.028

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.661

H2O24 mM hydrogen peroxideDNAdamaging

0.866

Levo10 ug/mL LevofloxacinDNAdamaging

-1.190

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.508

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.567

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.697

UVUV-irradiationDNAdamaging

1.011

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.176

Antimycin12.5-50 ug/mL Antimycin A?

-0.222

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.368

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.735

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.122

PA8240.2-2 ug/mL PA-824?

0.402

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.487

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.212

Verapamil50 uM Verapamil?

0.593

mercaptoethanol2 mM 2-Mercaptoethanol?

0.515

methoxatin10-20 ug/mL Methoxatin?